Loading clinical trials...
Loading clinical trials...
Spiriva Assessment of FEV1 - (SAFE-Portugal). The Effect of Inhaled Tiotropium Bromide (18 Mcg Once Daily) on the Change in FEV1 During Treatment in Patients With COPD. A Three-month Parallel Group, Double-blind, Randomised, Placebo-controlled Study.
Conditions
Interventions
Pulmonary function Testing
tiotropium bromide
Locations
33
Portugal
Hospital Garcia de Orta
Almada, Portugal
Hospital Fernando Fonseca
Amadora, Portugal
Hospital Santo Espírito de Angra do Heroismo
Angra Do Heroismo - Açores, Portugal
Hospital Infante D. Pedro
Aveiro, Portugal
Unidade Funcional de Infecciologia
Barreiro, Portugal
Hospital de S. Marcos
Braga, Portugal
Start Date
December 1, 2002
Primary Completion Date
April 1, 2004
Completion Date
April 1, 2004
Last Updated
November 1, 2013
NCT06831994
NCT02755974
NCT05050591
NCT05913765
NCT05592847
NCT00683722
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions